PSA velocity and doubling time in diagnosis and prognosis of prostate cancer
The impact of comorbidity and PSA doubling time on the risk of death in men experiencing PSA failure following radiation therapy with or with androgen deprivation therapy for unfavorable-risk prostate cancer
Oncoscience | Pretreatment prostate specific antigen doubling time as prognostic factor in prostate cancer patients
Summary of PSA Doubling Time and Velocity Definitions | Download Table
Roundtable Discussion: Morgans Addresses How PSA Levels Affect Nonmetastatic CRPC Treatment
Salvage Radiation Therapy Nomograms | Dan's Journey through Prostate Cancer
Implications of Prostate-Specific Antigen Doubling Time as Indicator of Failure after Surgery or Radiation Therapy for Prostate
Prostate Cancer Nomograms: PSA Doubling Time | Memorial Sloan Kettering Cancer Center
Proposal for a Standardized PSA Doubling-time Calculation | Anticancer Research
The impact of comorbidity and PSA doubling time on the risk of death in men experiencing PSA failure following radiation therapy with or with androgen deprivation therapy for unfavorable-risk prostate cancer
Management of Biochemically Recurrent Prostate Cancer: Ensuring the Right Treatment of the Right Patient at the Right Time | American Society of Clinical Oncology Educational Book
PSA doubling time (PSADT) and proximal PSA predict metastasis-free survival (MFS) in men with biochemically recurrent prostate c
Low detectable PSA after prostatectomy – watch or treat? | THE "NEW" PROSTATE CANCER INFOLINK
PSA doubling time predicts the outcome after active surveillance in screening‐detected prostate cancer: Results from the European randomized study of screening for prostate cancer, Sweden section - Ali - 2007 - International
Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen
PSA Doubling Time Calculator
GitHub - conan-koh123/Calculating-PSA-Doubling-Time-for-many-patients: R code to calculate PSA doubling time (in months) for many patients
A Commentary on PSA Velocity and Doubling Time for Clinical Decisions in Prostate Cancer
Cureus | Prognostic Factors for Prostate Cancer Endpoints Following Biochemical Failure: A Review of the Literature | Article
Diagnostics | Free Full-Text | 68Ga-PSMA PET/CT for Patients with PSA Relapse after Radical Prostatectomy or External Beam Radiotherapy
El tiempo de doblaje de PSA como nuevo método diagnóstico y pronóstico del cáncer de próstata
IL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resista
Implications of Prostate-Specific Antigen Doubling Time as Indicator of Failure after Surgery or Radiation Therapy for Prostate Cancer - ScienceDirect
![Risk of metastatic disease using [18F]PSMA-1007 PET/CT for primary prostate cancer staging | EJNMMI Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13550-021-00869-5/MediaObjects/13550_2021_869_Fig1_HTML.png "Risk of metastatic disease using [18F]PSMA-1007 PET/CT for primary prostate cancer staging | EJNMMI Research | Full Text")
Risk of metastatic disease using [18F]PSMA-1007 PET/CT for primary prostate cancer staging | EJNMMI Research | Full Text
Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen
